Study to Evaluate the Safety, Tolerability, and Action of AMG 357 in Females With Rheumatoid Arthritis

PHASE1TerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions

Rheumatoid Arthritis

Interventions

DRUG

AMG 357

Oral tablets in 20 count bottles. Dose strengths include 5, 25, and 50 mg tablets.

DRUG

Placebo

Oral tablets in 20 count bottles. Dose strengths include 5, 25, and 50 mg tablets.

Trial Locations (2)

Research Site, Duncansville

Research Site, Dallas